1887

Chapter 22 : Rabies

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Rabies, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815974/9781555814625_Chap22-1.gif /docserver/preview/fulltext/10.1128/9781555815974/9781555814625_Chap22-2.gif

Abstract:

The Rhabdoviridae are classified as a group based on a similar conical or bullet-shaped appearance by electron microscopy. The laboratory diagnosis of rabies is most often performed for the postmortem examination of animals that have potentially exposed a human to the disease by a bite or other transdermal contact with saliva or neural tissue. A review of 32 human rabies deaths in the United States from 1980 to 1996 identified agitation and confusion, hypersalivation, hydrophobia or aerophobia, limb pain, and weakness as the most commonly observed signs of clinical rabies. Rabies virus maintained in domestic dog populations accounts for 95% of all animal rabies cases reported globally and still accounts for most of the zoonotic impact of the disease, with 90% of the human exposures to rabies and 99% of the human rabies deaths worldwide attributed to this cycle. The recognition of each human rabies case is very important in identification of highest risk exposure routes, vectors, and rabies virus variants-information essential to the development of effective rabies control and exposure management protocols. The prompt management of potential human exposure to rabies is a critical component of human rabies prevention.

Citation: Trimarchi C, Rudd R. 2009. Rabies, p 363-386. In Specter S, Hodinka R, Young S, Wiedbrauk D (ed), Clinical Virology Manual, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815974.ch22
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555815974.ch22
1. Afshar, A. A. 1979. A review of non-bite transmission of rabies virus infection. Br. Vet. J. 135:142148.
2. Archana, C.,, K. Singh, and, V. S. Senthil. 2002. Detection of rabies antigen in experimental buffalo calves by DAS-ELISA. Indian J. Anim. Sci. 72:963964.
3. Arya, S. C. 1999. Therapeutic failures with rabies vaccines and rabies immunoglobulin. Clin. Infect. Dis. 29:1605.
4. Babiuk, L. A.,, J. Lewis,, S. Van den Hurk, and, R. Braun. 1999. DNA immunization: present and future, p. 163–180. In R. D. Schultz (ed.), Veterinary Vaccines and Diagnostics. Academic Press, New York, NY.
5. Badrane, H.,, and N. Tordo. 2001. Host switching in Lyssavirus history from the Chiroptera to the Carnivora orders. J. Virol. 75:80968104.
6. Baer, G. M.,, and T. L. Lentz. 1991. Rabies pathogenesis to the central nervous system, p. 106–120. In G. M. Baer (ed.), The Natural History of Rabies, 2nd ed. CRC Press, Boca Raton, FL.
7. Baer, G. M.,, J. Neville, and, G. S. Turner. 1996. Rabbis and Rabies: a Pictorial History of Rabies Through the Ages. Laboratorios Baer, Condessa, Mexico.
8. Bakker, A. B.,, W. E. Marissen,, R. A. Kramer,, A. B. Rice,, W. C. Weldon,, M. Niezgoda,, C. A. Hanlon,, S. Thijsse,, H. H. Backus,, J. de Kruif,, B. Dietzschold,, C. E. Rupprecht, and, J. Goudsmit. 2005. Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants. J. Virol. 79:90629068.
9. Barrat, J. 1996. Simple technique for the collection and shipment of brain specimens for rabies diagnosis, p. 425–432. In F. X. Meslin,, M. M. Kaplan, and, H. Koprowski (ed.), Laboratory Techniques in Rabies, 4th ed. World Health Organization, Geneva, Switzerland.
10. Belotto, A.,, L. Leanes,, M., Schneider,, H. Tamayo, and, E. Correa. 2005. Overview of rabies in the Americas. Virus Res. 111:512.
11. Bernard, K. W. 1986. Clinical rabies in humans, p. 43–48. In D. B. Fishbein,, L. A. Sawyer, and, W. G. Winkler (ed.), Rabies Concepts for Professionals, 2nd ed. Merieux Institute, Miami, FL.
12. Bingham, J.,, and M. van der Merwe. 2002. Distribution of rabies antigen in infected brain material: determining the reliability of different regions of the brain for the rabies fluorescent antibody test. J. Virol. Methods 101:8594.
13. Black, E. M.,, J. P. Lowings,, J. Smith,, P. R. Heaton, and, L. M. McElhinney. 2002. A rapid RT-PCR method to differentiate six established genotypes of rabies and rabies-related viruses using TaqMan technology. J. Virol. Methods 105:2535.
14. Blanton, J. D.,, A. Meadows,, S. M. Murphy,, J. Managan,, C. A. Hanlon,, M. L. Faber,, B. Dietzschold, and, C. E. Rupprecht. 2006. Vaccination of small Asian mongoose (Herpestes javanicus) against rabies. J. Wildl. Dis. 42:663666.
15. Blanton, J. D.,, C. A. Hanlon, and, C. E. Rupprecht. 2007. Rabies surveillance in the United States during 2006. J. Am. Vet. Med. Assoc. 231:540556.
16. Blenden, D. C.,, J. F. Bell,, A. T. Tsao, and, J. V. Umoh. 1983. Immunofluorescent examination of the skin of rabies infected animals as a means of early detection of rabies virus antigen. J. Clin. Microbiol. 18:631636.
17. Bourhy, H.,, P. E. Rollin,, J. Vincent, and, P. Sureau. 1989. Comparative field evaluation of the fluorescent-antibody test, virus isolation from tissue culture, and enzyme immunodiagnosis for rapid laboratory diagnosis of rabies. J. Clin. Microbiol. 27:519523.
18. Bourhy, H.,, B. Kissi, and, N. Tordo. 1993. Molecular diversity of the Lyssavirus genus. Virology 194:7081.
19. Bourhy H.,, and P. Perrin. 1996. Rapid rabies enzyme immuno-diagnosis (RREID) for rabies antigen detection, p. 105–113. In F. X. Meslin,, M. M. Kaplan, and, H. Koprowski (ed.), Laboratory Techniques in Rabies, 4th ed. World Health Organization, Geneva, Switzerland.
20. Brass, D. A. 1994. Prevalence and distribution of rabies in insectivorous bats, p. 131–150. In D. A. Brass (ed.), Rabies in Bats. Livia Press, Ridgefield, CT.
21. Briggs, D. J.,, and J. R. Schwenke. 1992. Longevity of rabies antibody titre in recipients of human diploid cell vaccine. Vaccine 10:125129.
22. Briggs, D. J.,, J. S. Smith,, F. L. Mueller,, J. Schwenke,, R. D. Davis,, C. R. Gordon,, K. Schweitzer,, L. A. Orciari,, P. A. Yager, and, C. E. Rupprecht. 1998. A comparison of two serological methods for detecting the immune response after rabies vaccination in dogs and cats being exported to rabies-free areas. Biologicals 26:347355.
23. Briggs, D. J.,, D. W. Dreesen,, U. Nicolay,, J. E. Chin,, R. Davis,, C. Gorden, and, A. Banzhoff. 2000. Purified Chick Embryo Cell Culture Rabies Vaccine: interchangeability with Human Diploid Cell Vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons. Vaccine 19:10551060.
24. Brochier, B.,, M. F. A. Aubert,, P. P. Pastoret,, E. Masson,, J. Schon,, M. Lombard,, G. Chappuis,, B. Languet, and, P. H. Desmettre. 1996. Field use of a vaccinia-rabies recombinant vaccine for the control of sylvatic rabies in Europe and North America. Rev. Sci. Tech. 15:947970.
25. Butts, C.,, I. Zubkoff,, D. S. Robbins,, S. Cao, and, M. Sarzotti. 1998. DNA immunization of infants: potential and limitations. Vaccine 16:14441449.
26. Centers for Disease Control. 1977. Rabies in a laboratory worker—New York. MMWR Morb. Mortal. Wkly. Rep. 26:183184.
27. Centers for Disease Control and Prevention. 1997. Human rabies—Montana and Washington, 1997. MMWR Morb. Mortal. Wkly. Rep. 46:770774.
28. Centers for Disease Control and Prevention. 2008. Human rabies prevention—United States, 2008: recommendations of the Advisory Committee on Immunizations Practices (ACIP). MMWR Recommend. Rep. 57(RR-3):128.
29. Centers for Disease Control and Prevention. 2003. First human death associated with raccoon rabies—Virginia, 2003. MMWR Morb. Mortal. Wkly. Rep. 52:11021103.
30. Centers for Disease Control and Prevention and the National Institutes of Health. 2007. Biosafety in Microbiological and Biomedical Laboratories, 5th ed. http://www.cdc.gov/od/ohs/biosfty/bmbl5/bmbl5toc.htm.
31. Charlton, K. M. 1988. The pathogenesis of rabies, p. 101–150. In J. B. Campbell and, K. M. Charlton (ed.), Rabies. Academic Press, Norwell, MA.
32. Childs, J. E.,, C. V. Trimarchi, and, J. W. Krebs. 1994. The epidemiology of bat rabies in New York State. Epidemiol. Infect. 113:501511.
33. Childs, J. E.,, L. Colby,, J. W. Krebs,, T. Strine,, M. Feller,, D. Noah,, C. Drenzek,, J. S. Smith, and, C. E. Rupprecht. 1997. Surveillance and spatiotemporal associations of rabies in rodents and lagomorphs in the United States, 1985–1994. J. Wildl. Dis. 33:2027.
34. Chutivongse, S.,, H. Wilde,, M. Benjavongkulchai,, P. Chomchey, and, S. Punthawong. 1995. Postexposure rabies vaccination during pregnancy: effect on 202 women and their infants. Clin. Infect. Dis. 20:818820.
35. Cleveland, S. 1998. Epidemiology and control of rabies: the growing problem of rabies in Africa. Trans. R. Soc. Trop. Med. Hyg. 92:131134.
36. Constantine, D. G. 1962. Rabies transmission by nonbite route. Public Health Rep. 77:287289.
37. Constantine, D. G. 1967. Bat rabies in the southwestern United States. Public Health Rep. 82:867888.
38. Conti, L. 2001. Available ELISA test not recommended for rabies pre-exposure titer or antemortem evaluation. Florida Department of Health EPI Update 2001. Florida Department of Health, Tallahassee, FL.
39. Cooper, A.,, and H. N. Poinar. 2000. Ancient DNA: do it right or not at all. Science 289:1139.
40. Crepin, P.,, L. Audry,, Y. Rotivel,, A. Gacoin,, C. Caroff, and, H. Bourhy. 1998. Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid. J. Clin. Microbiol. 36:11171121.
41. Da Rosa, E. S.,, I. Kotait,, T. F. Barbosa,, M. L. Carrieri,, P. E. Brandao,, A. S. Pinheiro,, A. L. Begot,, M. Y. Wada,, R. C. de Oliveira,, E. C. Grisard,, M. Ferreira,, R. J. Lima,, L. Montebello,, D. B. Medeiros,, R. C. Sousa,, G. Bensabath,, E. H. Carmo, and, P. F. Vasconcelos. 2006. Bat-transmitted human rabies outbreaks, Brazilian Amazon. Emerg. Infect. Dis. 12:11971202.
42. David, D.,, B. Yacobson,, D. Rotenberg,, N. Dveres,, I. Davidson, and, Y. Stram. 2002. Rabies virus detection by RT-PCR in decomposed naturally infected brains. Vet. Microbiol. 87:111118.
43. Davis, A. D.,, R. J. Rudd, and, R. A. Bowen. 2007. Effects of aerosolized rabies virus exposure on bats and mice. J. Infect. Dis. 195:11441150.
44. Davis, C.,, S. Neill, and, P. Raj. 1998. Microwave fixation of rabies specimens for fluorescent antibody testing. J. Virol. Methods 68:177182.
45. Debbie, J. G.,, and C. V. Trimarchi. 1970. Pantropism of rabies virus in free-ranging rabid red fox Vulpes fulva. J. Wildl. Dis. 6:500506.
46. Debbie, J. G.,, and C. V. Trimarchi. 1992. Rabies, p. 116–120. In A. E. Castro and, W. P. Heuschele (ed.), Veterinary Diagnostic Virology. Mosby Year Book, Boston, MA.
47. Debbie, J. G.,, and C. V. Trimarchi. 1997. Prophylaxis for suspected exposure to bat rabies. Lancet 350:17901791.
48. Dietzschold, B.,, M. Faber, and, M. J. Schnell. 2003. New approaches to the prevention and eradication of rabies. Expert Rev. Vaccines 2:399406.
49. Dimitrov, D. T.,, T. G. Hallam,, C. E. Rupprecht,, A. S. Turmelle, and, G. F. McKracken. 2007. Integrative models of bat rabies immunology, epizootiology and disease demography. J. Theor. Biol. 245:498509.
50. Dreesen, D. W. 1997. A global review of rabies vaccines for human use. Vaccine 15:S2S6.
51. Dreesen, D. W.,, and C. A. Hanlon. 1998. Current recommendations for the prophylaxis and treatment of rabies. Drugs 56:801809.
52. Dreesen, D. W.,, K. W. Bernard,, R. A. Parker,, A. J. Deutsch, and, J. Brown. 1986. Immune complex-like disease in 23 persons following a booster dose of rabies human diploid cell vaccine. Vaccine 4:4549.
53. East, M. L.,, H. Hofer,, J. H. Cov,, U. Wulle,, H. Wiik, and, C. Pitra. 2001. Regular exposure to rabies virus and lack of symptomatic disease in Serengeti spotted hyenas. Proc. Natl. Acad. Sci. USA 98:1502615031.
54. Eidson, M.,, S. D. Matthews,, A. l. Willsey,, B. Cherry,, R. J. Rudd, and, C. V. Trimarchi. 2005. Rabies infection in a pet guinea pig and seven pet rabbits. J. Am. Vet. Med. Assoc. 227:932935.
55. Elmgren, L. D.,, and A. I. Wandeler. 1996. Competitive ELISA for the detection of rabies virus-neutralizing antibodies, p. 200–208. In F. X. Meslin,, M. M. Kaplan, and, H. Koprowski (ed.), Laboratory Techniques in Rabies, 4th ed. World Health Organization, Geneva, Switzerland.
56. Ermine, A.,, N. Tordo, and, H. Tsiang. 1988. Rapid diagnosis of rabies infection by means of a dot hybridization assay. Mol. Cell. Probes 2:7582.
57. Everard, C. O.,, and J. D. Everard. 1985. Mongoose rabies in Grenada, p. 43–70. In P. J. Bacon (ed.), Population Dynamics of Rabies in Wildlife. Academic Press, New York, NY.
58. Fangtao, L.,, C. Shubeng,, W. Yinzhon,, S. Chenze,, Z. Fanzhen, and, W. Guanfu. 1988. Use of serum and vaccine in combination for prophylaxis following exposure to rabies. Rev. Infect. Dis. 10:767770.
59. Fearneyhough, G. 1998. A summary of the Texas oral rabies vaccination program (OVRP) for canine rabies 1995–1998. (Abstract.) Proc. IX Int. Meet. Res. Adv. Rabies Control Amer., Jalisco, Mexico, 8 to 12 December 1998.
60. Feder, H. M.,, R. Nelson, and, H. W. Reiher. 1997. Bat bite? Lancet 350:1300.
61. Fekadu, M. 1991. Canine rabies, p. 367–378. In G. M. Baer (ed.), The Natural History of Rabies, 2nd ed. CRC Press, Boca Raton, FL.
62. Fekadu, M.,, J. H. Shaddock, and, G. M. Baer. 1981. Intermittent excretion of rabies virus in the saliva of a dog two and six months after it had recovered from experimental rabies. Am. J. Trop. Med. Hyg. 30:11131115.
63. Fekadu, M.,, J. H. Shaddock, and, G. M. Baer. 1982. Excretion of rabies virus in the saliva of dogs. J. Infect. Dis. 145:715719.
64. Fekadu, M.,, T. Endeshaw,, A. Wondimagegnehu,, Y. Bogale,, T. Teshager, and, J. G. Olsen. 1996. Possible human-to-human transmission of rabies in Ethiopia. Ethiop. Med. J. 34:123127.
65. Fenner, F. J.,, E. O. Gibbs,, F. A. Murphy,, R. Rott,, M. J. Studdert, and, D. O. White. 1993. Veterinary Virology, 2nd ed. Academic Press, Toronto, Canada.
66. Fishbein, D. B. 1991. Rabies in humans, p. 519–549. In G. M. Baer (ed.), The Natural History of Rabies, 2nd ed. CRC Press, Boca Raton, FL.
67. Franka, R.,, S. Svrcek,, M. Madar,, M. Kolesarova,, A. Ondrejkova,, R. Ondrejka,, Z. Benisek,, J. Suli, and, S. Vicek. 2004. Quantification of the effectiveness of laboratory diagnostics of rabies using classical and molecular-genetic methods. Vet. Med. 49:259267.
68. Fries, L. F.,, J. Tartaglia,, J. Taylor,, E. K. Kaufman,, B. Meignier,, E. Paoletti, and, S. Plotkin. 1996. Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system. Vaccine 14:428434.
69. Fu, Z. F. 1997. Rabies and rabies research: past, present and future. Vaccine 15:S20S24.
70. Fu, Z. F.,, E. Wickstrom,, M. Jiang,, S. Corisdoe,, B. Dietz-schold, and, H. Koprowski. 1996. Inhibition of rabies virus infection by an oligodeoxynucleotide complimentary to rabies virus genomic RNA. Antisense Nucleic Acid Drug Dev. 6:8793.
71. Gibbons, R. V.,, R. C. Holman,, S. R. Mosberg, and, C. E. Rupprecht. 2002. Knowledge of bat rabies and human exposure among United States cavers. Emerg. Infect. Dis. 8:532534.
72. Gode, G. R.,, A. V. Raju,, T. S. Jayalakshmi,, H. L. Kaul, and, N. K. Bide. 1976. Intensive care in rabies therapy: clinical observations. Lancet ii:6.
73. Goldwasser, R. A.,, and R. E. Kissling. 1958. Fluorescent antibody staining of street and fixed rabies virus antigens. Proc. Soc. Exp. Biol. Med. 98:219223.
74. Griego, R. D.,, T. Rosen,, I. F. Orengo, and, J. E. Wolf. 1995. Dog, cat and human rabies: a review. J. Am. Acad. Dermatol. 33:10191029.
75. Guerra, M. A.,, A. T. Curns,, C. E. Rupprecht,, C. A. Hanlon,, J. W. Krebs, and, J. E. Childs. 2003. Skunk and raccoon rabies in the eastern United States: temporal and spatial analysis. Emerg. Infect. Dis. 9:11431150.
76. Habel, K. 1945. Seroprophylaxis in experimental rabies. Public Health Rep. 60:545551.
77. Hamir, A. N.,, Z. F. Moser,, F. Fu,, B. Dietzschold, and, C. E. Rupprecht. 1995. Immunohistochemical test for rabies: identification of a diagnostically superior monoclonal antibody. Vet. Rec. 136:295296.
78. Hanlon, C. A. 2007. Rabies in terrestrial animals, p. 201–258. In A. C. Jackson and, W. H. Wunner (ed.), Rabies, 2nd ed. Academic Press, New York, NY.
79. Hanlon, C. A.,, C. DeMattos,, C. DeMattos,, J. Shaddock, and, C. E. Rupprecht. 1998. The next generation in passive protection for postexposure prophylaxis. (Abstract.) Proc. IX Int. Meet. Res. Adv. Rabies Control Amer., Jalisco, Mexico, 8 to 12 December 1998.
80. Hanlon, C. A.,, J. S. Smith,, G. R. Anderson, and the National Working Group on Rabies Prevention and Control. 1999. Recommendations of a national working group on prevention and control of rabies in the United States. Article II: laboratory diagnosis of rabies. J. Am. Vet. Med. Assoc. 10:14441447.
81. Hanlon, C. A,, I. V. Kuzmin,, J. D. Blanton,, W. C. Weldon,, J. S. Manangan, and, C. E. Rupprecht. 2005. Efficacy of rabies biologics against new lyssaviruses from Eurasia. Virus Res. 111:4454.
82. Heaton, P. R.,, P. Johnstone,, L. M. McElhinney,, R. Cowley,, E. O’Sullivan, and, J. E. Whitby. 1997. Heminested PCR assay for detection of six genotypes of rabies and rabies-related viruses. J. Clin. Microbiol. 35:27622766.
83. Hellenbrand, W.,, C. Meyer,, G. Rasch,, I. Steffins, and, A. Ammon. 2005. Cases of rabies in Germany following organ transplantation. Eurosurveillance 10:5253.
84. Hemachudha, T.,, and S. Wacharapluesadee. 2004. Antemortem diagnosis of human rabies. Clin. Infect. Dis. 39:10851086.
85. Hemachudha, T.,, B. Sunsaneewitayakul,, T. Desudchit,, C. Suankratay,, C. Sittipunt,, S. Wacharapluesadee,, P. Khawplod,, H. Wilde, and, A. C. Jackson. 2006. Failure of therapeutic coma and ketamine for therapy of human rabies. J. Neurovirol. 12:407409.
86. Hooper, P. T.,, R. A. Lunt,, A. R. Gould,, H. Samaratunga,, A. D. Hyatt,, L. J. Gleeson,, B. J. Rodwell,, C. E. Rupprecht,, J. S. Smith, and, P. K. Murray. 1997. A new lyssavirus—the first endemic rabies-related virus recognized in Australia. Bull. Inst. Pasteur 95:209218.
87. Hu, L.,, C. Ngichabe,, C. Trimarchi,, J. Esposito, and, F. Scott. 1997. Raccoon poxvirus live recombinant feline panleukopenia virus VP2 and rabies virus glycoprotein bivalent vaccine. Vaccine 15:14661472.
88. Hughes, G. J.,, J. S. Smith,, C. A. Hanlon, and, C. E. Rupprecht. 2004. Evaluation of a TaqMan PCR assay to detect rabies virus RNA: influence of sequence variation and application to quantification of viral loads. J. Clin. Microbiol. 42:299306.
89. Hughes, G. J.,, L. A. Orciari, and, C. E. Rupprecht. 2005. Evolutionary timescale of rabies virus adaptation to North American bats inferred from the substitution rate of the nucleoprotein gene. J. Gen. Virol. 86:14671474.
90. Hummeler, K.,, H. Koprowski, and, T. J. Wiktor. 1967. Structure and development of rabies virus in tissue culture. Nature 294:275278.
91. International Air Transport Association. 2006. IATA Dangerous Goods Regulations 2006, 47th ed. International Air Transport Association, Geneva, Switzerland.
92. Jackson, A. C. 2005. Recovery from rabies (editorial). N. Engl. J. Med. 352:25492550.
93. Jackson, A. C. 2007. Pathogenesis, p. 341–381. In A. C. Jackson and, W. H. Wunner (ed.), Rabies, 2nd ed. Academic Press, New York, NY.
94. Jackson, A. C.,, P. Rasalingham, and, W. C. Weli. 2006. Comparative pathogenesis of recombinant rabies vaccine strain SAD-L16 and SAD D29 with replacement of Arg333 in the glycoprotein after peripheral inoculation of neonatal mice: less neurovirulent strain is a stronger inducer of neuronal apoptosis. Acta Neuropathol. 111:372378.
95. Jenkins, S. R.,, B. D. Perry, and, W. G. Winkler. 1998. Ecology and epidemiology of raccoon rabies. Rev. Infect. Dis. 10:S620S625.
96. Johnson, N.,, S. M. Brookes,, A. R. Fooks, and, R. S. Ross. 2005. Review of human rabies cases in the UK and in Germany. Vet. Rec. 157:715717.
97. Kamolvarin, N.,, T. Tirawatnpong,, R. Rattanasiwamoke,, S. Tirawatnpong,, T. Panpanich, and, T. Hemachudha. 1993. Diagnosis of rabies by polymerase chain reaction with nested primers. J. Infect. Dis. 167:207210.
98. Kaplan, C. 1985. Rabies: a worldwide disease, p. 1–21. In P. J. Bacon (ed.), Population Dynamics of Rabies in Wildlife. Academic Press, New York, NY.
99. Kaplan, M. M. 1996. Safety precautions in handling rabies virus, p. 3–8. In F. X. Meslin,, M. M. Kaplan, and, H. Koprowski (ed.), Laboratory Techniques in Rabies, 4th ed. World Health Organization, Geneva, Switzerland.
100. Kaplan, M. M.,, T. J. Wiktor,, R. F. Maes,, J. B. Campbell, and, H. Koprowski. 1967. Effect of polyions on the infectivity of rabies virus in tissue culture: construction of a single-cycle growth curve. J. Virol. 1:145151.
101. Kelly, R. M.,, and P. L. Strick. 1997. Retrograde transport of rabies virus through the cerebello-thalamocortical circuits of primates. Abstr. Soc. Neurosci. 23:1828
102. King, A. A.,, J. J. Sands, and, J. S. Porterfield. 1984. Antibody-mediated enhancement of rabies virus infection in a mouse macrophage cell line (P388DI). J. Gen. Virol. 65:10911093.
103. Kissi, B.,, N. Tordo, and, H. Bourhy. 1995. Genetic polymorphism in the rabies virus nucleoprotein gene. Virology 209:526537.
104. Knobel, D. L.,, S. Cleveland,, P. G. Coleman,, E. M. Fevre,, M. I. Meltzer, and, M. E. Miranda. 2005. Re-evaluating the burden of rabies in Africa and Asia. Bull. W. H. O. 83:360368.
105. Kohler, G.,, and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495497.
106. Koprowski, H. 1991. The virus: overview, p. 27–29. In G. M. Baer (ed.), The Natural History of Rabies, 2nd ed. CRC Press, Boca Raton, FL.
107. Koprowski, H.,, and H. R. Cox. 1948. Studies on chick embryo adapted rabies virus I. Culture characteristics and pathogenicity. J. Immunol. 60:533539.
108. Krebs, J. W.,, M. L. Wilson, and, J. E. Childs. 1995. Rabies-epidemiology, prevention and future research. J. Mammal. 76:681694.
109. Krebs, J. W.,, E. J. Mandel,, D. L. Swerdlow, and, C. E. Rupprecht. 2005. Rabies surveillance in the United States during 2004. J. Am. Vet. Med. Assoc. 227:19121925.
110. Kristensson, D.,, and Y. Olsson. 1973. Diffusion pathways and retrograde axonal transport of protein tracers in peripheral nerves. Prog. Neurobiol. 1:85106.
111. Kuzmin, I. V.,, G. J. Hughes,, A. D. Botvinkin,, L. A. Orciari, and, C. E. Rupprecht. 2005. Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype definition. Virus Res. 111:2843.
112. Kwok, S.,, and R. Higuchi. 1989. Avoiding false positives with PCR. Nature 339:237238.
113. Lafon, M. 2005. Mini review—the rabies virus. Rabies virus receptors. J. Neurovirol. 11:8287.
114. Lafon, M. 2007. Immunology, p. 489–504. In A. C. Jackson and, W. H. Wunner (ed.), Rabies, 2nd ed. Academic Press, New York, NY.
115. Langevin, C.,, H. Jaaro,, S. Bressanelli,, M. Fainzilber, and, C. Tuffereau. 2002. Rabies virus glycoprotein (RVG) is a trimeric ligand for the N-terminal cysteine-rich domain of the mammalian p75 neurotrophin receptor. J. Biol. Chem. 277:3765537662.
116. Lembo, T.,, M. Niezgoda,, A. Velasco-Villa,, S. Cleaveland,, E. Ernest, and, C. E. Rupprecht. 2006. Evaluation of a direct, rapid immunohistochemical test for rabies diagnosis. Emerg. Infect. Dis. 12:310313.
117. Le Mercier, P.,, Y. Jacob, and, N. Tordo. 1997. The complete Mokola virus genome sequence: structure of the RNA-dependent RNA polymerase. J. Gen. Virol. 78:15711576.
118. Lentz, T. L.,, P. T. Wilson,, E. Hawrot, and, D. W. Speicher. 1984. Amino acid sequence similarity between rabies virus glycoprotein and snake venom curare mimetic neurotoxins. Science 226:847848.
119. Lepine, P.,, and P. Atanasiu. 1996. Histopathological diagnosis, p. 66–79. In F. X Meslin,, M. M. Kaplan, and, H. Koprowski (ed.), Laboratory Techniques in Rabies, 4th ed. World Health Organization, Geneva, Switzerland.
120. Leslie, M.,, S. Messenger,, R. E. Rohde,, J. Smith,, R. Chesier,, C. A. Hanlon, and, C. E. Rupprecht. 2006. Bat-associated rabies virus in skunks. Emerg. Infect. Dis. 12:12741277.
121. Lewis, P.,, Y. Fu, and, T. L. Lentz. 2000. Rabies virus entry at the neuromuscular junction in nerve-muscle cocultures. Muscle Nerve 23:720730.
122. Lodmell, D. L.,, N. B. Ray,, M. J. Parnell,, L. C. Ewalt,, C. A. Hanlon,, J. H. Shaddock,, D. S. Sanderlin, and, C. E. Rupprecht. 1998. DNA immunization protects non-human primates against rabies virus. Nat. Med. 4:949952.
123. Lodmell, D. L.,, M. J. Parnell,, M. J. Baily,, L. C. Ewalt, and, C. A. Hanlon. 2002. Rabies DNA vaccination of nonhuman primates: postexposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers. Vaccine 20:22212228.
124. MacInnes, C. D. 1988. Control of wildlife rabies, p. 381–406. In J. B. Campbell and, K. M. Charlton (ed.), Rabies. Kluwer Academic Publishers, Boston, MA.
125. Madhusudana, S. N.,, J. P. Paul,, V. K. Abhilash, and, M. S. Suja. 2004. Rapid diagnosis of rabies in humans and animals by a dot blot enzyme immunoassay. Int. J. Infect. Dis. 8:339345.
126. Mansel, G. A. 1951. Royal Canadian Mounted Police Report. “G” Division, Port Harrison, Quebec.
127. Matyas, B. T.,, M. W. McGuill, and, A. DeMaria. 1999. Reemergence of rabies in the US. Infect. Med. 16:129138.
128. McGarvey, P. B.,, J. Hammond,, M. M. Dienelt,, D. C. Hooper,, F. H. Michaels,, Z. F. Fu,, B. Dietzschold, and, H. Koprowski. 1995. Expression of the rabies virus glycoprotein in transgenic tomatoes. Bio/Technology 13:14841487.
129. Meltzer, M. I.,, and C. E. Rupprecht. 1998. A review of the economics of the prevention and control of rabies. Part I: global impact and rabies in humans. Pharmacoeconomics 14:365383.
130. Meslin, F. X.,, D. B. Fishbein, and, H. C. Matter. 1994. Rationale and prospects for rabies elimination in developing countries. Curr. Top. Microbiol. Immunol. 187:126.
131. Messenger, S. L.,, J. S. Smith, and, C. E. Rupprecht. 2002. Emerging epidemiology of bat-associated cryptic cases of rabies in humans in the United States. Clin. Infect. Dis. 35:738747.
132. Mondul, A. M.,, J. W. Krebs, and, J. E. Childs. 2003. Trends in national surveillance for rabies among bats in the United States (1993–2000). J. Am. Vet. Med. Assoc. 222:633639.
133. Moromoto, K.,, M. Patel,, S. Corisdeo,, D. C. Hooper,, Z. F. Fu, and, C. E. Rupprecht. 1996. Characterization of an unique variant of bat rabies responsible for newly emerging human cases in the United States. Proc. Natl. Acad. Sci. USA 93:56535658.
134. Murphy, F. A. 1986. The rabies virus and pathogenesis of the disease, p. 11–16. In D. B. Fishbein,, L. A. Sawyer, and, W. G. Winkler (ed.), Rabies Concepts for Professionals, 2nd ed. Merieux Institute, Miami, FL.
135. Nadin-Davis, S. A. 1998. Polymerase chain reaction protocols for rabies virus discrimination. J. Virol. Methods 75:18.
136. Nadin-Davis, S. A. 2007. Molecular epidemiology, p. 69–122. In A. C. Jackson and, W. H. Wunner (ed.), Rabies, 2nd ed. Academic Press, New York, NY.
137. Nadin-Davis, S. A.,, and J. Bingham. 2004. Europe as a source of rabies for the rest of the world, p. 259–280. In A. A. King,, A. R. Fooks,, M. Aubert, and, A. I. Wandeler (ed.), Historical Perspective of Rabies in Europe and the Mediterranean Basin. OIE, Paris, France.
138. Nadin-Davis S. A.,, W. Huang, and, A. I. Wandeler. 1996. The design of strain-specific polymerase chain reactions for discrimination of the raccoon rabies virus strain from indigenous rabies viruses of Ontario. J. Virol. Methods 57:141156.
139. Nadin-Davis, S. A.,, M. Sheen, and, A. I. Wandeler. 2003. Use of discriminatory probes for strain typing of formalin-fixed rabies virus-infected tissues by in situ hybridization. J. Clin. Microbiol. 1:43434352.
140. Negri, A. 1903. Contributo allo studio della etiologia della rabia. Boll. Soc. Med. Chir. Pavia 3:8895.
141. Nel, L.,, C. T Sabeta,, B. Von Teichman,, J. B. Jaftha,, C. E. Rupprecht, and, J. Bingham. 2005. Mongoose rabies in southern Africa: a re-evaluation based on molecular epidemiology. Virus Res. 109:165173.
142. Nicholson, K. G. 1994. Rabies, p. 595–620. In A. J. Zuckerman,, J. E. Banatvala, and, J. R. Pattison (ed.), Principles and Practice of Clinical Virology, 3rd ed. John Wiley & Sons, New York, NY.
143. Niezgoda, M.,, D. J. Briggs,, J. Shaddock,, D. W. Dreesen, and, C. E. Rupprecht. 1997. Pathogenesis of experimentally induced rabies in domestic ferrets. Am. J. Vet. Res. 58:13271331.
144. Noah, D. L.,, M. G. Smith,, J. C. Gottardt,, J. W. Krebs,, D. Green, and, J. E. Childs. 1996. Mass human exposure to rabies in New Hampshire: exposures, treatment, and cost. Am. J. Public Health 86:11491151.
145. Noah, D. L.,, C. L. Drenzek,, J. S. Smith,, J. W. Krebs,, L. Orciari,, J. Shaddock,, D. Sanderlin,, S. Whitfield,, M. Fekadu,, J. G. Olson,, C. E. Rupprecht, and, J. E. Childs. 1998. Epidemiology of human rabies in the United States, 1980 to 1996. Ann. Intern. Med. 128:922930.
146. Office International des Epizooties. 1996. Rabies, p. 211–213. In R. Reichard (ed.), OIE Manual of Standards for Diagnostic Tests and Vaccines, 3rd ed. Office International des Epizooties, Paris, France.
147. Orciari, L. A. 1995. Genetic analysis of rabies virus isolates from skunks in the United States. Master’s thesis. University of Georgia, Athens, GA.
148. Parviz, S.,, R. Chotani,, J. McCormick,, S. Fisher-Hoch, and, S. Luby. 2004. Rabies deaths in Pakistan: results of ineffective post-exposure treatment. Int. J. Infect. Dis. 8:346352.
149. Perl, D. P.,, and P. F. Good. 1991. The pathology of rabies in the central nervous system, p. 163–190. In G. M. Baer (ed.), The Natural History of Rabies, 2nd ed. CRC Press, Boca Raton, FL.
150. Picard-Meyer, E.,, V. Bruyere,, J. Barrat,, E. Tissot,, M. J. Barrat, and, F. Cliquet. 2004. Development of a hemi-nested RT-PCR method for the specific determination of European bat lyssavirus 1: comparison with other rabies diagnostic methods. Vaccine 22:19211929.
151. Powell, J. 1997. Proficiency testing in the rabies diagnostic laboratory, p. 33. Abstr. 8th Annu. Rabies Amer. Conf., Kingston, Ontario, Canada, 2 to 6 November 1997.
152. Radlich, W. 2003. Rabies direct fluorescent antibody test: the need for proper tissue sampling, p. 68. Abstr. XIV Int. Conf. Rabies Amer., Philadelphia, PA, 19 to 24 October 2003.
153. Rudd, R. J.,, and C. V. Trimarchi. 1980. Tissue culture technique for routine isolation of street strain rabies virus. J. Clin. Microbiol. 12:590593.
154. Rudd, R. J.,, and C. V. Trimarchi. 1987. Comparison of sensitivity of BHK-21 and murine neuroblastoma cells in the isolation of a street strain rabies virus. J. Clin. Microbiol. 25:14561458.
155. Rudd, R. J.,, and C. V. Trimarchi. 1989. The development and evaluation of an in vitro virus isolation procedure as a replacement for the mouse inoculation test in rabies diagnosis. J. Clin. Microbiol. 27:25222528.
156. Rudd, R. J.,, and C. V. Trimarchi. 1997. Evans Blue counter-stain in the rabies fluorescent antibody test, p. 62. Abstr. 8th Annu. Rabies Amer. Conf., Kingston, Ontario, Canada, 2 to 6 November 1997.
157. Rudd, R. J.,, J. S. Smith,, P. A. Yager,, L. A. Orciari, and, C. V. Trimarchi. 2005. A need for standardized rabies virus diagnostic procedures: effect of cover glass mountant on the reliability of antigen detection by the fluorescent antibody test. Virus Res. 111:8388.
158. Rupprecht, C. E. 1996. The pathobiology of bat rabies in the USA: considerations for human prevention. (Abstract.) Symp. Bat Rabies, U.S. Animal Health Association, Little Rock, AR, 4 October 1996.
159. Rupprecht, C. E.,, B. Dietzschold,, J. H. Cox, and, L. G. Schneider. 1989. Oral vaccination of raccoons (Procyon lotor) with an attenuated (SAD-B19) rabies vaccine. J. Wildl. Dis. 25:548554.
160. Rupprecht, C. E.,, C. A. Hanlon,, M. Niezgoda,, J. R. Buchanan,, D. Diehl, and, H. Koprowski. 1993. Recombinant rabies vaccine: efficacy assessment in free ranging animals. Onderstepoort J. Vet. Res. 60:463468.
161. Rupprecht, C. E.,, J. S. Smith,, J. Krebs,, M. Niezgoda, and, J. E. Childs. 1996. Current issues in rabies prevention in the United States. Public Health Rep. 111:400407.
162. Rupprecht, C. E.,, L. Blass,, K. Smith,, L. A. Orciari,, M. Niezgoda,, S. G. Whitfield,, R. V. Gibbons,, M. Guerra, and, C. A. Hanlon. 2001. Human infection due to recombinant vaccinia-rabies glycoprotein virus. N. Engl. J. Med. 345:582586.
163. Rupprecht, C. E.,, C. A. Hanlon, and, T. Hemachudha. 2002. Rabies re-examined. Lancet Infect. Dis. 2:327343.
164. Sacramento, D.,, H. Bourhy, and, N. Tordo. 1991. PCR technique as an alternative method for rabies diagnosis and molecular epidemiology of rabies virus. Mol. Cell. Probes 6:229240.
165. Saiki, R. K. 1989. The design and optimization of the PCR, p. 7–16. In H. A. Erlich (ed.), PCR Technology: Principles and Applications for DNA Amplification. Stockton Press, New York, NY.
166. Savy, V.,, and P. Atanasiu. 1978. Rapid immunoenzymatic technique for titration of rabies antibodies IgG and IgM. Dev. Biol. Stand. 40:247253.
167. Shope, R. E.,, F. A. Murphy,, A. K. Harrison,, O. R. Causey,, G. E. Kemp,, D. I. Simpson, and, D. L. Moore. 1970. Two African viruses serologically and morphologically related to rabies virus. J. Virol. 6:690692.
168. Shope, R. E.,, and R. B. Tesh. 1987. Lyssaviruses, p. 509–534. In R. R. Wagner (ed.), The Rhabdoviruses. Plenum Press, New York, NY.
169. Slate, D.,, C. E. Rupprecht,, J. A. Rooney,, D. Donovan,, D. H. Lein, and, R. B. Chipman. 2005. Status of oral rabies vaccination in wild carnivores in the United States. Virus Res. 111:6876.
170. Sloan, S. E.,, C. Hanlon,, W. Weldon,, M. Niezgoda,, J. Blanton,, J. Self,, K. J. Rowly,, R. B. Mandell,, G. J. Babcock,, W. D. Thomas, Jr.,, C. E. Rupprecht, and, D. M. Ambrosino. 2007. Identification and characterization of human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates. Vaccine 25:28002810.
171. Smith, A. L.,, G. H. Tignor,, R. W. Emmons, and, J. D. Woodie. 1978. Isolation of field rabies virus strains in CER and murine neuroblastoma cell cultures. Intervirology 9:359361.
172. Smith, J. S. 1989. Rabies virus epitopic variation: use in ecologic studies. Adv. Virus Res. 36:215253.
173. Smith, J. S. 1996. New aspects of rabies with emphasis on epidemiology, diagnosis, and prevention of the disease in the United States. Clin. Microbiol. Rev. 9:166176.
174. Smith, J. S. 1999. Rabies virus, p. 1099–1106. In P. R. Murray,, E. J. Baron,, M. A. Pfaller,, F. C. Tenover, and, R. H. Yolken (ed.), Manual of Clinical Microbiology, 7th ed. ASM Press, Washington, DC.
175. Smith, J. S.,, and D. H. Seidel. 1993. Rabies: a new look at an old disease, p. 82–106. In J. L. Melnick (ed.), Progress in Medical Virology. Karger, Basel, Switzerland.
176. Smith, J. S.,, C. L. McClelland,, F. L. Reid, and, G. M. Baer. 1982. Dual role of the immune response in street rabies virus infection of mice. Infect. Immun. 35:213217.
177. Smith, J. S.,, F. L. Reid-Sanden,, L. F. Roumillat,, C. V. Trimarchi,, K. Clark,, G. M. Baer, and, W. G. Winkler. 1986. Demonstration of antigen variation among rabies virus isolates by using monoclonal antibodies to nucleocapsid proteins. J. Clin. Microbiol. 24:573580.
178. Smith, J. S.,, D. B. Fishbein,, C. E. Rupprecht, and, K. Clark. 1991. Unexplained rabies in three immigrants in the United States. N. Engl. J. Med. 324:205211.
179. Smith, J. S.,, L. A. Orciari,, P. A. Yager,, H. D. Seidel, and, C. K. Warner. 1992. Epidemiologic and historical relationships among 87 rabies virus isolates as determined by limited sequence analysis. J. Infect. Dis. 166:296307.
180. Smith, J. S.,, L. A. Orciari, and, P. A. Yager. 1995. Molecular epidemiology of rabies in the United States. Semin. Virol. 6:387400.
181. Smith, J. S.,, P. A. Yager, and, G. M. Baer. 1996. A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus-neutralizing antibody, p. 181–192. In F. X. Meslin,, M. M. Kaplan, and, H. Koprowski (ed.), Laboratory Techniques in Rabies, 4th ed. World Health Organization, Geneva, Switzerland.
182. Sriaroon, C.,, S. Daviratanasilpa,, P. Sansomranjai,, P. Khawplod,, T. Hemachudha,, T. Khamoltham, and, H. Wilde. 2003. Rabies in a Thai child treated with the eight-site post-exposure regimen without rabies immune globulin. Vaccine 21:35253526.
183. Srinivasan, A.,, E. C. Burton,, M. J. Kuehnert,, C. Rupprecht,, W. L. Sutker,, T. G. Ksiazek,, C. D. Paddock,, J. Guarner,, W. Shieh,, C. Goldsmith,, C. A. Hanlon,, J. Zoretic,, B. Fischbach,, M. Niezgoda,, W. H. El-Feky,, L. Orciari,, E. Q. Sanchez,, A. Likos,, G. B. Klintmalm,, D. Cardo,, J. LeDuc,, M. E. Chamberland,, D. B. Jernigan, and, S. R. Zaki. 2005. Transmission of rabies virus from an organ donor to four transplant recipients. N. Engl. J. Med. 352:11031111.
184. Steele, J. H.,, and P. J. Fernandez. 1991. History of rabies and global aspects, p. 1–24. In G. M. Baer (ed.), The Natural History of Rabies, 2nd ed. CRC Press, Boca Raton, FL.
185. Sun, B.,, M. Auslander,, L. Conti,, P. Ettestad,, M. Leslie, and, F. E. Sorhage. 2007. Compendium of animal rabies prevention and control, 2007. J. Am. Vet. Med. Assoc. 230:833840.
186. Superti, F.,, M. Derer, and, H. Tsaing. 1984. Mechanism of rabies virus entry into CER cells. J. Gen. Virol. 65:781789.
187. Sureau, P.,, P. Ravisse, and, P. E. Rollin. 1991. Rabies diagnosis by animal inoculation, identification of Negri bodies, or ELISA, p. 203–217. In G. M. Baer (ed.), The Natural History of Rabies, 2nd ed. CRC Press, Boca Raton, FL.
188. Taylor, J.,, C. Trimarchi,, R. Weinberg,, B. Languet,, F. Guillemin,, P. Desmettre, and, E. Paoletti. 1991. Efficacy studies on a canarypox-rabies recombinant virus. Vaccine 9:190193.
189. Taylor, J.,, B. Meignier,, J. Tartaglia,, B. Lanquet,, J. Vander-Hoeven,, G. Franchini,, C. Trimarchi, and, E. Paoletti. 1995. Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian species. Vaccine 13:539549.
190. Theodorides, J. 1986. Histoire de la Rage. Mason, Paris, France.
191. Thoulouze, M. I.,, M. Lafage,, M. Schachner,, U. Hartmenn,, H. Cremer, and, M. Lafon. 1998. The neural cell adhesion molecule is a receptor for rabies virus. J. Virol. 72:71817190.
192. Tierkel, E. S.,, and P. Atanasiu. 1996. Rapid microscopic examination for Negri bodies and preparation of specimens for biological tests, p. 55–65. In F. X. Meslin,, M. M. Kaplan, and, H. Koprowski (ed.), Laboratory Techniques in Rabies, 4th ed. World Health Organization, Geneva, Switzerland.
193. Tordo, N. 1996. Characteristics and molecular biology of rabies virus, p. 28–52. In F. X. Meslin,, M. M. Kaplan, and, H. Koprowski (ed.), Laboratory Techniques in Rabies, 4th ed. World Health Organization, Geneva, Switzerland.
194. Tordo, N.,, H. Bourhy, and, D. Sacramento. 1992. Polymerase chain reaction technology for rabies virus, p. 389–405. In Y. Becker and, G. Darai (ed.), Diagnosis of Human Viruses by Polymerase Chain Reaction Technology, Frontiers in Virology. Springer-Verlag Press, Berlin, Germany.
195. Tordo, N.,, H. Bourhy, and, D. Sacramento. 1995. PCR technology for Lyssavirus diagnosis, p. 125–145. In J. Clewly (ed.), The Polymerase Chain Reaction (PCR) for Human Viral Diagnosis. CRC Press, London, United Kingdom.
196. Tordo, N.,, A. Benmansour,, C. Calisher,, R. G. Dietzgen,, R.-X. Fang, and, A. O. Jackson. 2004. Rhabdoviridae, p. 623–644. In C. M. Fauquet,, M. A. Mayo,, J. Maniloff,, U. Dessellberger and, L. A. Ball (ed.), Virus Taxonomy, VIIIth Report of the ICTV (International Committee on the Taxonomy of Viruses). Academic Press, London, United Kingdom.
197. Tornatore, C. S.,, and J. R. Richert. 1990. CNS demyelination associated with diploid cell rabies vaccine. Lancet 335:13461347.
198. Trimarchi, C. V.,, and J. G. Debbie. 1991. The fluorescent antibody in rabies, p. 220–233. In G. M. Baer (ed.), The Natural History of Rabies, 2nd ed. CRC Press, Boca Raton, FL.
199. Trimarchi, C. V.,, and J. S. Smith. 2002. Diagnostic evaluation, p. 307–349. In A. C. Jackson and, W. H. Wunner (ed.), Rabies. Academic Press, New York, NY.
200. Trimarchi, C. V.,, and S. Nadin-Davis. 2007. Diagnostic evaluation, p. 411–469. In A. C. Jackson and, W. H. Wunner (ed.), Rabies, 2nd ed. Academic Press, New York, NY.
201. Trimarchi, C. V.,, R. J. Rudd, and, M. K. Abelseth. 1986. Experimentally induced rabies in four cats inoculated with a rabies virus isolated from a bat. Am. J. Vet. Res. 47:777780.
202. Trimarchi, C. V.,, R. J. Rudd, and, M. Safford. 1996. An in vitro virus neutralization test for rabies antibody, p. 193–199. In F. X. Meslin,, M. M. Kaplan, and, H. Koprowski (ed.), Laboratory Techniques in Rabies, 4th ed. World Health Organization, Geneva, Switzerland.
203. Tsiang, H. 1993. Pathophysiology of rabies virus infection of the nervous system. Adv. Virus Res. 42:375412.
204. Tuffereau, C.,, J. Benejean,, D. Blondel,, B. Kieffer, and, A. Flamand. 1998. Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus. EMBO J. 17:72507259.
205. Uhaa, I. J.,, V. N. Dato,, F. E. Sorhage,, J. W. Beckley,, D. E. Roscoe,, R. D. Gorsky, and, D. B. Fishbein. 1992. Benefits and costs of using an orally absorbed vaccine to control rabies in raccoons. J. Am. Vet. Med. Assoc. 201:18731882.
206. Umoh, J. V.,, and D. C. Blenden. 1983. Use of monoclonal antibodies in diagnosis of rabies virus infection and differentiation of rabies and rabies-related viruses. J. Virol. Methods 1:3346.
207. Van Regenmortel, H. V.,, C. M. Fauquet,, D. H. L. Bishop,, E. B. Carstens,, M. K. Estes,, S. M. Lemon,, J. Maniloff,, M. A. Mayo,, D. J. McGeoch,, C. R. Pringle, and, R. B. Wickner. 2000. Virus Taxonomy: Seventh Report of the International Committee on Taxonomy of Viruses. Academic Press, San Diego, CA.
208. Vernon, S. K.,, A. R. Neurath, and, B. A. Rubin. 1972. Electron microscopic studies on the structure of rabies virus. J. Ultrastruct. Res. 41:2942.
209. Wakely, P. R.,, N. Johnson,, L. M. McElhinney,, D. Marston,, J. Sawyer, and, A. R. Fooks. 2005. Development of a real-time, TaqMan reverse transcription-PCR assay for the detection and differentiation of lyssavirus genotypes 1, 5, and 6. J. Clin. Microbiol. 43:27862792.
210. Wandeler, A. I.,, S. A. Nadin-Davis,, R. R. Tinline, and, C. E. Rupprecht. 1994. Rabies epidemiology: some ecological and evolutionary perspectives, p. 297–324. In C. E. Rupprecht,, B. Dietzschold, and, H. Koprowski (ed.). Lyssaviruses. Springer-Verlag, Berlin, Germany.
211. Warner, C. K.,, S. G. Whitfield,, M. Fekadu, and, H. Ho. 1997. Procedures for reproducible detection of rabies virus antigen, mRNA and genome in situ in formalin fixed tissues. J. Virol. Methods 67:512.
212. Warrell, M. J.,, and D. A. Warrell. 2004. Rabies and other lyssavirus diseases. Lancet 363:959969.
213. Webster, L. T.,, and J. R. Dawson. 1935. Early diagnosis of rabies by mouse inoculation. Measurement of humoral immunity to rabies by mouse protection test. Proc. Soc. Exp. Biol. Med. 32:570573.
214. Webster, W. A.,, and G. A. Casey. 1996. Virus isolation in neuroblastoma cell culture, p. 96–104. In F. X. Meslin,, M. M. Kaplan, and, H. Koprowski (ed.), Laboratory Techniques in Rabies, 4th ed. World Health Organization, Geneva, Switzerland.
215. Whitby, J. E.,, P. Johnstone, and, C. Sillero-Zubiri. 1997. Rabies virus in the decomposed brain of an Ethiopian wolf detected by nested reverse transcription-polymerase chain reaction. J. Wildl. Dis. 33:912915.
216. Whitfield, S. G.,, M. Fekadu,, J. H. Shaddock,, M. Niezgoda,, C. K. Warner, and, L. Messenger. 2001. A comparative study of the fluorescent antibody test for rabies diagnosis in fresh and formalin-fixed brain tissue specimens. J. Virol. Methods 95:145151.
217. Wiktor, T. J.,, and H. Koprowski. 1965. Successful immunization of primates with rabies vaccine prepared in human diploid cell strain WI38. Proc. Soc. Exp. Biol. Med. 118:10691073.
218. Wiktor, T. J.,, A. Flamand, and, H. Koprowski. 1980. Use of monoclonal antibodies in diagnosis of rabies virus infection and differentiation of rabies and rabies-related viruses. J. Virol. Methods 1:3346.
219. Wiktor, T. J.,, R. I. Macfarlan,, K. J. Reagan,, B. Dietzschold,, P. J. Curtis,, W. H. Wunner,, M. P. Kieny,, R. Lathe,, J. P. Lecocq,, M. Mackett,, B. Moss, and, H. Koprowski. 1984. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc. Natl. Acad. Sci.USA 81:71947198.
220. Wilde, H.,, P. Chomchey,, P. Puyaratabandhu, and, S. Chutivongse. 1989. Purified equine rabies immune globulin: a safe and affordable alternative to rabies immune globulin. Bull. W. H. O. 67:731736.
221. Wilkinson, L. 1988. Understanding the nature of rabies: an historical perspective, p. 1–23. In J. B. Campbell and, K. M. Charlton (ed.), Rabies. J. B. Kluwer Academic Publishers, Boston, MA.
222. Willoughby, R. E., Jr.,, K. S. Tieves,, G. M. Hoffman,, N. S. Ghanayem,, C. M. Amlie-Lefond,, M. J. Schwabe,, M. J. Chusid, and, C. E. Rupprecht. 2005. Survival after treatment of rabies with induction of coma. N. Engl. J. Med. 352:25082514.
223. Winkler, W. G.,, T. R. Fashinell,, L. Leffingwell,, P. Howard, and, P. Conomy. 1973. Airborne rabies transmission in a laboratory worker. JAMA 226:12191221.
224. World Health Organization. 1984. WHO Expert Committee on Rabies, 7th report. WHO Technical Report Series, no. 709. World Health Organization, Geneva, Switzerland.
225. World Health Organization. 1992. WHO Expert Committee on Rabies, 8th Report. WHO Technical Report Series, no. 824. World Health Organization, Geneva, Switzerland.
226. World Health Organization. 1994. Workshop on Genetic and Antigenic Molecular Epidemiology of Lyssaviruses, p. 1–14. WHO, Geneva, Switzerland.
227. World Health Organization. 1997. World Health Report 1996. World Health Organization, Geneva, Switzerland.
228. World Health Organization. 2005. WHO Expert Consultation on Rabies: First Report. WHO Technical Report Series, no. 931. WHO, Geneva, Switzerland.
229. Wunner, W. H. 2007. Rabies virus, p. 23–68. In A. C. Jackson and, W. H. Wunner (ed.), Rabies, 2nd ed. Academic Press, New York, NY.
230. Wunner, W. H.,, J. K. Larson,, B. Dietzschold, and, C. L. Smith. 1988. The molecular biology of rabies viruses. Rev. Infect. Dis. 10:S771S784.
231. Wunner, W. H.,, C. H. Calisher,, R. G. Dietzgen,, R. G. Jackson,, A. O. Kitajima,, M. F. Lafon,, J. C. Leong,, S. T. Nichol,, D. Peters,, J. S. Smith, and, P. J. Walker. 1995. Rhabdoviridae, p. 275–280. In F. A. Murphy (ed.), Classification and Nomenclature of Viruses, Sixth Report of the International Committee on Taxonomy of Viruses. Springer-Verlag, New York, NY.
232. Wunner, W. H.,, C. Pallatroni, and, P. J. Curtis. 2004. Selection of genetic inhibitors of rabies virus. Arch. Virol. 149:16531662.
233. Wyatt, J. D.,, W. H. Barker,, Bennett, N. M.,, and C. A. Hanlon. 1999. Human rabies postexposure prophylaxis during a raccoon rabies epizootic in New York, 1993 and 1994. Emerg. Infect. Dis. 5:111.
234. Xiang, Z. Q.,, G. P. Gao,, A. Reyes-Sandoval,, Y. Li,, J. M. Wilson, and, H. C. J. Ertl. 2003. Oral vaccination of mice with adenoviral vectors is not impaired by pre-existing immunity to the vaccine carrier. J. Virol. 77:1078010789.
235. Yarosh, O. K.,, A. I. Wandeler,, F. L. Graham,, J. B. Campbell, and, L. Prevec. 1996. Human adenovirus type 5 vectors expressing rabies glycoprotein. Vaccine 14:12571264.
236. Yusibov, V.,, D. C. Hooper,, S. V. Spitsin,, N. Fleysh,, R. B. Kean, and, T. Mikheeva. 2002. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine 20:31553164.
237. Zaidman, G. W.,, and A. Billingsly. 1998. Corneal impression test for the diagnosis of acute rabies encephalitis. Ophthalmology 105:249251.
238. Zenyu, G.,, W. Zhen,, C. Enfu,, H. Fan,, L. Junfen,, L. Yixin,, D. Gangqiang, and, R. E. Fontaine. 2007. Human rabies cluster following badger bites, People’s Republic of China. Emerg. Infect. Dis. 13:19551957.
239. Zhou, D.,, A. Cun,, Y. Li,, Z. Q. Xiang, and, H. C. J. Ertl. 2006. A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus. Mol. Ther. 14:662672.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error